Patents by Inventor Jiri Jan Krepinsky

Jiri Jan Krepinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS AND METHODS FOR BREAST CANCER DETECTION AND RISK ASSESSMENT
    Publication number: 20120214245
    Abstract: The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff's reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.
    Type: Application
    Filed: February 8, 2012
    Publication date: August 23, 2012
    Applicant: Atossa Genetics, Inc.
    Inventors: Jiri Jan Krepinsky, Rudolf Furrer, Ka Sing Yeung
  • Systems and methods for breast cancer detection and risk assessment
    Patent number: 8133737
    Abstract: The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff's reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.
    Type: Grant
    Filed: January 31, 2011
    Date of Patent: March 13, 2012
    Assignee: Atossa Genetics, Inc.
    Inventors: Jiri Jan Krepinsky, Rudolf Furrer, Ka Sing Yeung
  • SYSTEMS AND METHODS FOR BREAST CANCER DETECTION AND RISK ASSESSMENT
    Publication number: 20110124110
    Abstract: The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff's reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.
    Type: Application
    Filed: January 31, 2011
    Publication date: May 26, 2011
    Applicant: DR. SUSAN LOVE RESEARCH FOUNDATION
    Inventors: JIRI JAN KREPINSKY, RUDOLF FURRER, KA SING YEUNG
  • Methods for detection of breast cancer
    Patent number: 7879614
    Abstract: The invention relates to a simple screening test for neoplasia, a precancerous condition, or cancer of the breast. A method is described whereby a breast cancer marker is detected in breast fluid. In a particular embodiment, the method involves treating samples of breast fluids with an aldehyde detecting reagent without any prewashing. The appearance in breast fluids of a marker that is detected by an aldehyde detecting reagent, such as a Schiff's reagent, correlates very well with the disease status of the breast cancer subjects from which the fluids were obtained. Screening test kits are also provided.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: February 1, 2011
    Assignee: Dr. Susan Love Research Foundation
    Inventors: Jiri Jan Krepinsky, Rudolf Furrer, Ka Sing Yeung
  • Carbamates of ergolines and therapeutic compositions therewith
    Patent number: 4057635
    Abstract: Ergoline carbamates are disclosed, which have proven to be effective spasmolytic and vasodilatory drugs. They are derivatives of D-6-methyl-8.beta.-(methanol)-9,10-didehydroergoline (also called lysergol). Three convenient methods for their preparation are also disclosed. The toxicity of these compounds is extremely low.
    Type: Grant
    Filed: August 19, 1975
    Date of Patent: November 8, 1977
    Assignee: Simes Societa Italiana Medicinali e Sintetici S.p.A.
    Inventors: Giorgio Ferrari, Jiri Jan Krepinsky
  • Carbamates of ergolines
    Patent number: 3944582
    Abstract: Ergoline carbamates are disclosed, which have proven to be effective spasmolytic and vasodilatory drugs. They are derivatives of D-6-methyl-8.beta.-(methanol)-9,10-didehydroergoline (also called lysergol). Three convenient methods for their preparation are also disclosed. The toxicity of these compounds is extremely low.
    Type: Grant
    Filed: May 20, 1974
    Date of Patent: March 16, 1976
    Assignee: Simes Societa Italiana Medicinali e Sintetici S.p.A.
    Inventors: Giorgio Ferrari, Jiri Jan Krepinsky